Filing Details

Accession Number:
0001104659-20-139741
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-28 16:02:21
Reporting Period:
2020-12-23
Accepted Time:
2020-12-28 16:02:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1805890 Fusion Pharmaceuticals Inc. FUSN () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1193586 Adams Street Partners Llc 1 N Wacker Dr, Suite 2700
Chicago IL 60606
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-12-23 734 $12.39 562,245 No 4 S Indirect See footnotes
Common Stock Disposition 2020-12-23 564 $12.39 431,586 No 4 S Indirect See footnotes
Common Stock Disposition 2020-12-23 547 $12.39 418,645 No 4 S Indirect See footnotes
Common Stock Disposition 2020-12-23 819 $12.39 626,681 No 4 S Indirect See footnotes
Common Stock Disposition 2020-12-23 1,905 $12.39 1,458,699 No 4 S Indirect See footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnotes
No 4 S Indirect See footnotes
No 4 S Indirect See footnotes
No 4 S Indirect See footnotes
No 4 S Indirect See footnotes
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.705 to $12.00.
  2. The shares are held directly by Adams Street 2014 Direct Fund LP ("AS 2014").
  3. The shares are held directly by Adams Street 2015 Direct Venture/Growth Fund LP ("AS 2015").
  4. The shares are held directly by Adams Street 2016 Direct Venture/Growth Fund LP ("AS 2016").
  5. The shares are held directly by Adams Street 2017 Direct Venture/Growth Fund LP ("AS 2017").
  6. The shares are held directly by Adams Street Venture/Growth Fund VI LP ("ASVG VI").
  7. Adams Street Partners, LLC as the managing member of the general partner of the general partner of each of AS 2014, AS 2015, AS 2016, AS 2017 and ASVG VI (collectively the "Funds"), may be deemed to beneficially own the shares held by the Funds. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by the Funds. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray and Fred Wang disclaim beneficial ownership of the shares held by the Funds except to the extent of their pecuniary interest therein.